疑夕2015-04-16 22:26
$ADRO(ADRO)$ 继续上涨,目前合理价位为$40,如果明年II期数据为阳性,涨到$64是比较合理的,如果通过II期数据够好可以直接申报NDA,价位可以提到$96,期间如果新增临床前项目,价格应该会更高,现在大家的热情比较高,可能炒到虚高的价位,但做长线投资就无所谓了,II期数据出来前是无法定价的。查看全文
scintilla2015-04-16 22:20
$ADRO(ADRO)$ 这种平台型公司,有BTD,又有orphan drug status,还有J&J和NVS背书,市值应该按着juno给,看5-6billion市值吧,现在差不多3billion。看着办吧。查看全文
$Aduro BioTech Inc(ADRO)$ 8-K Current report, items 5.03, 5.07, 7.01, and 9.01 Accession Number: 0001193125-20-261293 Act: 34 Size: 202 KB 网页链接
$Aduro BioTech Inc(ADRO)$ 8-K Current report, item 7.01 Accession Number: 0001193125-20-252523 Act: 34 Size: 66 KB 网页链接
$Aduro BioTech Inc(ADRO)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-20-252525 Act: 34 Size: 26 KB 网页链接
$Aduro BioTech Inc(ADRO)$ 8-K Current report, item 8.01 Accession Number: 0001193125-20-249542 Act: 34 Size: 77 KB 网页链接
$Aduro BioTech Inc(ADRO)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-20-249551 Act: 34 Size: 36 KB 网页链接
$Aduro BioTech Inc(ADRO)$ 内部交易: 2020-09-15,SVP, GC and Secretary,Ferber Celeste ,卖出,2396普通股, $2.39
$Aduro BioTech Inc(ADRO)$ 内部交易: 2020-09-15,Chief Legal Officer,Templeman Blaine ,卖出,12369普通股, $2.39
$Aduro BioTech Inc(ADRO)$ 内部交易: 2020-09-15,总裁 and CEO,ISAACS STEPHEN T ,卖出,32481普通股, $2.39
$Aduro BioTech Inc(ADRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-20-016852 Size: 5 KB 网页链接
$Aduro BioTech Inc(ADRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-20-016853 Size: 5 KB 网页链接